Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Peter Zelenka"'
Autor:
Angelika Reiner-Concin, Christian Sebesta, Wolfgang Hinterberger, Peter Zelenka, Reinhard Ruckser, Veronika Buxhofer-Ausch, Isabel Schmid, Emil Ogris, Georg Tatzreiter, Karl Heinz Habertheuer, Christoph Ausch, Walter Hruby, Margareta Hinterberger-Fischer, Peter Kier
Publikováno v:
European Journal of Haematology. 73:143-146
A 57-yr-old woman with multiple myeloma received an autologous tandem transplant at a 4-month interval. She was conditioned twice with 225 mg/m 2 melphalan. After the second transplant, interstitial pneumonitis (IP) ensued. The clinical course was li
Autor:
Peter Zelenka, Walter Hruby, Christian Sebesta, Wolfgang Hinterberger, Engelbert Knosp, Karl-Heinz Habertheuer, Stefan Dorner, Peter Kier, Georg Tatzreiter, Veronika Buxhofer, Reinhard Ruckser
Publikováno v:
European Journal of Haematology. 67:128-132
We describe in detail a 67-yr-old woman who was treated with a cytostatic combination chemotherapy for newly diagnosed common-acute lymphoblastic leukaemia. At the end of induction therapy, the patient acquired invasive mould infection affecting lung
Autor:
Veronika, Buxhofer-Ausch, Reinhard, Ruckser, Peter, Kier, Karl Heinz, Habertheuer, Peter, Zelenka, Georg, Tatzreiter, Christoph, Ausch, Isabel, Schmid, Walter, Hruby, Angelika, Reiner-Concin, Christian, Sebesta, Emil, Ogris, Margareta, Hinterberger-Fischer, Wolfgang, Hinterberger
Publikováno v:
European journal of haematology. 73(2)
A 57-yr-old woman with multiple myeloma received an autologous tandem transplant at a 4-month interval. She was conditioned twice with 225 mg/m2 melphalan. After the second transplant, interstitial pneumonitis (IP) ensued. The clinical course was lif
Autor:
Veronika Buxhofer-Ausch, Karl-Heinz Habertheuer, Selma Hoenigschnabl, Christian Sebesta, Elvira Kitzweger, Georg Tatzreiter, Reinhard Ruckser, Peter Zelenka, Angelika Reiner-Concin, Peter Kier
Publikováno v:
Journal of Clinical Oncology. 30:e14087-e14087
e14087 Background: Immunotherapy in real-life, unselected patients with metastatic colorectal cancer (mCRC) was analyzed retrospectively at a single center in Austria. Methods: We have treated 137 mCRC patients with at least one antibody containing t